IL1B and neurodegenerative disease: After 5 to 8 days, labeled astrocytes were treated or not for 24h with IL-1β, an inflammatory mediator shown to be upregulated in the context of multiple conditions such as brain injury, neurodegenerative diseases and infections (30–32).